argenx SE | ARGX - Cost Of Sales

Stock Price
676.60
Daily Change
6.00 0.89%
Monthly
5.85%
Yearly
38.59%
Q2 Forecast
630.50

argenx SE reported $149.69M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
AstraZeneca USD 3.27B 471M Dec/2025
Galapagos EUR 455K 84.28M Dec/2025
Genmab DKK 81M 23M Dec/2025
GlaxoSmithKline GBP 2.61B 377M Dec/2025
GRIFOLS EUR 1.29B 163.12M Dec/2025
Hikma Pharmaceutical USD 959M 492.5M Dec/2025
Qiagen NV USD 217.43M 29.65M Dec/2025
UCB EUR 1.07B 146M Dec/2025